AU6678194A - Agents for the prevention and treatment of huntington's disease and other neurological disorders - Google Patents

Agents for the prevention and treatment of huntington's disease and other neurological disorders

Info

Publication number
AU6678194A
AU6678194A AU66781/94A AU6678194A AU6678194A AU 6678194 A AU6678194 A AU 6678194A AU 66781/94 A AU66781/94 A AU 66781/94A AU 6678194 A AU6678194 A AU 6678194A AU 6678194 A AU6678194 A AU 6678194A
Authority
AU
Australia
Prior art keywords
huntington
disease
prevention
agents
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66781/94A
Inventor
Johanna Eugenie Bergmann
Rick E. Preddie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2094169 external-priority patent/CA2094169A1/en
Application filed by Individual filed Critical Individual
Publication of AU6678194A publication Critical patent/AU6678194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU66781/94A 1993-04-16 1994-04-14 Agents for the prevention and treatment of huntington's disease and other neurological disorders Abandoned AU6678194A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA 2094169 CA2094169A1 (en) 1993-04-16 1993-04-16 Agents for the prevention and cure of huntington disease in humans: cdna, precursor polypeptide hormone and active hormone reconstructed from the antisense strand of the huntingtondisease gene, "huntingtin"
CA2094169 1993-04-16
US5057893A 1993-04-20 1993-04-20
US050578 1993-04-20
PCT/EP1994/001164 WO1994024279A2 (en) 1993-04-16 1994-04-14 Agents for the prevention and treatment of huntington's disease and other neurological disorders

Publications (1)

Publication Number Publication Date
AU6678194A true AU6678194A (en) 1994-11-08

Family

ID=25676093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66781/94A Abandoned AU6678194A (en) 1993-04-16 1994-04-14 Agents for the prevention and treatment of huntington's disease and other neurological disorders

Country Status (2)

Country Link
AU (1) AU6678194A (en)
WO (1) WO1994024279A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
US5741645A (en) * 1993-06-29 1998-04-21 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
DK0842332T3 (en) 1995-08-03 2001-08-06 Europa Metalli Spa Low-release water installation components made of copper-based copper-containing alloys and a method of obtaining these
US6093549A (en) * 1995-11-09 2000-07-25 The Johns Hopkins University Huntingtin-associated protein-related assays
WO1997018825A1 (en) * 1995-11-17 1997-05-29 The University Of British Columbia PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO
EP0956365A4 (en) * 1996-08-28 2004-08-25 Univ Johns Hopkins Med Method for detecting cell proliferative disorders

Also Published As

Publication number Publication date
WO1994024279A3 (en) 1995-03-30
WO1994024279A2 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU7397094A (en) Prevention and treatment of alzheimer's disease
IL112050A0 (en) Methods of inhibiting alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
EP0820467A4 (en) Methods of treating disorders of the eye
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
AU3364499A (en) Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
AU5518694A (en) Treatment of a group of related disorders
EP0735897A4 (en) "prophylaxis of allergic disease"
AU5430894A (en) Diagnosis of eye disorders
AU1807592A (en) New combination preparation for treatment of parkinson's disease
ZA947912B (en) Treatment of medical disorders associated with free radical formation
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
IL107515A (en) Diagnosis of mental disorders
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU1294195A (en) Compositions and methods for the treatment of dry eyes and other ocular disorders
AU5397994A (en) Treatment of skin disorders
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states